Bone Diseases, Infectious: Clinical Trials

4 trials for Bone Diseases, Infectious, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 21Completed 1

Follow Bone Diseases, Infectious: new trials by email Literature Review of Bone Diseases, Infectious trials Research Report on Bone Diseases, Infectious

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections
Cefadroxil, Cephalexin - Osteomyelitis, Septic Arthritis
Phase 1CompletedUniversity of Colorado, Denver172019-05-012021-06-02
Drug Penetration Into Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery
Debio 1450 - Bone Diseases, Infectious
Phase 1CompletedDebiopharm International SA172016-04-012017-10-18
Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children
Ceftaroline Fosamil - Hematogenously Acquired Staphylococcus Aureus Osteomyelitis, Bone Infection
Phase 1 / Phase 2CompletedBaylor College of Medicine112015-06-032021-11-02
Ferumoxytol-enhanced Imaging of Osteomyelitis
Ferumoxides 11.2Mg Solution for Injection - Osteomyelitis
Phase 1CompletedUniversity of New Mexico122014-02-122023-07-25

Narrower conditions

Osteomyelitis (3)  ·  Arthritis, Infectious (1)  ·  Pyomyositis (1)

Broader conditions

Bone Diseases (4)  ·  Infections (4)  ·  Musculoskeletal Diseases (4)  ·  Arthritis (1)  ·  Joint Diseases (1)  ·  Muscular Diseases (1)  ·  Myositis (1)  ·  Nervous System Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Suppuration (1)

Interventions

Cefadroxil (1)  ·  Ceftaroline (1)  ·  Cephalexin (1)  ·  Injections (1)  ·  Solutions (1)  ·  afabicin (1)  ·  ferumoxides (1)

Sponsors

Baylor College of Medicine (1)  ·  Debiopharm International SA (1)  ·  University of Colorado, Denver (1)  ·  University of New Mexico (1)

Countries

United States (4)

Top investigators

Andrew Haynes, MD (1)  ·  Laurel Sillerud, PhD (1)  ·  Sheldon L. Kaplan, MD (1)

Results publications

PMID 30559136